Reports
Sale
Global Clinical Trial Imaging Market Size, Share, Growth, Forecast: By Products and Services: Services, Software; By Application: Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Others; By Modality: Magnetic Resonance Imaging, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Clinical Trial Imaging Market Outlook:
The global clinical trial imaging market size was valued at USD 1.40 billion in 2023, driven by the increasing number of clinical trials organized in different therapeutic areas across the globe. The market size is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032 to achieve a value of USD 2.82 billion by 2032.
Clinical Trial Imaging: Introduction
Clinical trial imaging is known as the use of imaging techniques in clinical setting to explore, evaluate the efficacy, safety, of the drugs, devices, or interventions that are being analyzed or undergoing research for trials. Imaging modalities like magnetic resonance Imaging MRI, computerized tomography CT, positron emission tomography PET are often used to visualize, analyze, anatomical structures, physiological functions, and disease related changes within the human body.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in Clinical Trial Imaging Market
There are several key trends running in the market and some of them include the rising demand for clinical imaging to provide more accurate results and analysis of symptoms and structural issues. Quantitative imaging biomarkers are being emphasized for use due to this reason. Additionally, the integration of artificial intelligence, different approaches for multi-modality imaging, and increasing advancement and development in imaging technology is also a key trend in the market. Some other key trends in the market involves better data management and analysis, virtual imaging and trials, regulatory requirements and standardizations, along with increasing utilization of advanced imaging technology.
Clinical Trial Imaging Market Segmentations
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Products and Services
- Services
- Software
Market Breakup by Application
- Trial Design Consulting Services
- Read Analysis Services
- Operational Imaging Services
- Imaging Software
Market Breakup by Modality
- Magnetic Resonance Imaging
- Computed Tomography
- Ultrasound
- Positron Emission Tomography
- X-Ray
- Echocardiography
- Other Modalities
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Medical Device Manufacturers
- Academic and Government Research Institutes
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Clinical Trial Imaging Market Scenario
The market for clinical trial imaging has been witnessing evident growth and is expected to grow steadily in coming years as well. The market for clinical trial imaging is driven by the increasing demand for correct and reliable imaging data for medical research.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
There are several factors responsible for market growth due to which the market is driven by, and they involve the increasing number of clinical trials organized in different therapeutic areas, including oncology, neurology, and cardiovascular diseases, among others. Due to the rising demand for personalized medicine and precision therapies, market is witnessing growth as it requires imaging biomarkers to perform the imaging process.
The market is also influenced by technological advancements enabling researchers to make more informed decisions. The market for clinical trial imaging is witnessing growth globally, and North America and Europe are dominating the market due to the presence of well-established research infrastructure, a large number of clinical trials.
Clinical Trial Imaging Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Navitas Life Sciences
- BioTelemetry
- ICON PLC
- IXICO plc.
- Image Core Lab
- anagram 4 clinical trials
- Quotient Sciences
- WORLDCARE CLINICAL
- Paraxel International Corporation
- Median Technologies
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Products and Services |
|
| Breakup by Application |
|
| Breakup by Modality |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Trial Imaging Market Overview
3.1 Global Clinical Trial Imaging Market Historical Value (2017-2023)
3.2 Global Clinical Trial Imaging Market Forecast Value (2024-2032)
4 Global Clinical Trial Imaging Market Landscape
4.1 Image Guided Surgery: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Image Guided Surgery: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Global Clinical Trial Imaging Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Clinical Trial Imaging Market Segmentation
6.1 Global Clinical Trial Imaging Market by Products and Services
6.1.1 Market Overview
6.1.2 Services
6.1.3 Software
6.2 Global Clinical Trial Imaging Market by Application
6.2.1 Market Overview
6.2.2 Trial Design Consulting Services
6.2.3 Read Analysis Services
6.2.4 Operational Imaging Services
6.2.5 Imaging Software
6.3 Global Clinical Trial Imaging Market by Modality
6.3.1 Market Overview
6.3.2 Magnetic Resonance Imaging
6.3.3 Computed Tomography
6.3.4 Ultrasound
6.3.5 Positron Emission Tomography
6.3.6 X-Ray
6.3.7 Echocardiography
6.3.8 Other Modalities
6.4 Global Clinical Trial Imaging Market by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical and Biotechnology Companies
6.4.3 Medical Device Manufacturers
6.4.4 Academic and Government Research Institutes
6.5 Global Clinical Trial Imaging Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Clinical Trial Imaging Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Clinical Trial Imaging Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Clinical Trial Imaging Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Clinical Trial Imaging Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Clinical Trial Imaging Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Navitas Life Sciences
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 BioTelemetry
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 ICON PLC
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 IXICO plc.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Image Core Lab
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 anagram 4 clinical trials
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Quotient Sciences
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 WORLDCARE CLINICAL
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Paraxel International Corporation
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Median Technologies
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1.40 billion in 2023, driven by the rising demand for clinical imaging to provide more accurate results.
The market size is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032 and reach a market value of USD 2.82 billion by 2032.
The increasing number of clinical trials organized in different therapeutic areas are the key drivers for the market.
The rising demand for clinical imaging to provide more accurate results are major key trends in the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America has been leading the global market.
The products and services in the market include services and software.
The clinical trial imaging finds wide applications in trial design consulting services, read analysis services, operational imaging services, and imaging software.
The modalities in the market include magnetic resonance imaging, computed tomography, ultrasound, positron emission tomography, X-ray, echocardiography, among other modalities.
The end-users in the market can be categorised into pharmaceutical and biotechnology companies, medical device manufacturers, academic and government research institutes.
Key players involved in the market are Navitas Life Sciences, BioTelemetry, ICON PLC, IXICO plc., Image Core Lab, anagram 4 clinical trials, Quotient Sciences, WORLDCARE CLINICAL, Paraxel International Corporation, and Median Technologies.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER